Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, July 23, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Genetically Characterized FFPE Tissue Samples
Tuesday, February 25, 2014
CancerSeq™ - New range of tissue samples from AMSBIO.

Automated TruSeq® Stranded Total RNA Library Preparation Method
Tuesday, February 25, 2014
Stranded Total RNA sequencing library preparation using epMotion minimizes hands-on time.

Pathway Genomics Launches Hereditary Colorectal Cancer Genetic Test
Thursday, February 20, 2014
Test uses NGS technology to identify gene alterations or mutations.

Crown Bioscience to Showcase Novel “in life” Platforms for Oncology
Tuesday, February 11, 2014
Company will highlight its expertise in Oncology Drug Discovery at AACR 2014.

GenomOncology To Enable CompanionDxTM Clinical Cancer Panels
Monday, February 10, 2014
The GO Clinical WorkbenchTM is selected to launch a series of next generation sequencing (NGS)-based assays.

Horizon Discovery Launches GENASSIST Line of Kits and Reagents for Gene-Editing, utilizing CRISPR Technology
Monday, February 10, 2014
The first products and services from GENASSIST™ enable easier, robust implementation of CRISPR and rAAV gene editing experiments.

Fluxion Biosciences Expands IsoFlux Discovery Services Capabilities with Clinical Sample Procurement
Monday, February 10, 2014
New capability provides a full-service option for circulating tumor cell studies.

Exiqon Releases New Online Search Tool for Gene Expression Studies
Thursday, February 06, 2014
New version of miRSearch for rapid retrieval of detailed information about microRNA.

University of Pittsburgh Selects GenomOncology
Wednesday, February 05, 2014
Company’s GenomAnalytics™ platform and services selected to support research efforts.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 640
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv